> 47- Are morphological and structural MRI characteristics related to specific cognitive impairments in neurofibromatosis type 1 (NF1) children?Baudou E, Nemmi F, Biotteau M, Maziero S, Assaiante C, Cignetti F, Vaugoyeau M, Audic F, Peran P, Chaix Y.
Eur J Paediatr Neurol. 2020 Jul 31:S1090-3798(20)30144-6. doi: 10.1016/j.ejpn.2020.07.003. Online ahead of print. > 28- Functional and Structural Integrity of Frontoparietal Connectivity in Traumatic and Anoxic Coma.Peran P, Malagurski B, Nemmi F, Sarton B, Vinour H, Ferre F, Bounes F, Rousset D, Mrozeck S, Seguin T, Riu B, Minville V, Geeraerts T, Lotterie JA, Deboissezon X, Albucher JF, Fourcade O, Olivot JM, Naccache L, Silva S.
Crit Care Med. 2020 May 11. doi: 10.1097/CCM.0000000000004406. > 26- Interhemispheric distribution of amyloid and small vessel disease burden in cerebral amyloid angiopathy-related intracerebral hemorrhage.Planton M, Pariente J, Nemmi F, Albucher JF, Calviere L, Viguier A, Olivot JM, Salabert AS, Payoux P, Peran P, Raposo N.
Eur J Neurol. 2020 May 11. doi: 10.1111/ene.14301. > 11- Action and Non-Action Oriented Body Representations: Insight from Behavioural and Grey Matter Modifications in Individuals with Lower Limb Amputation.Palermo L, Di Vita A, Boccia M, Nemmi F, Brunelli S, Traballesi M, De Giorgi R, Galati G, Guariglia C.
Biomed Res Int. 2018 Oct 18;2018:1529730. doi: 10.1155/2018/1529730. eCollection 2018. > 44- Grey Matter changes in treatment-resistant depression during electroconvulsive therapy.Yrondi A, Nemmi F, Billoux S, Giron A, Sporer M, Taib S, Salles J, Pierre D, Thalamas C, Rigal E, Danet L, Pariente J, Schmitt L, Arbus C, Péran P.
J Affect Disord. 2019 Jul 31;258:42-49. doi: 10.1016/j.jad.2019.07.075. > 25- A totally data-driven whole-brain multimodal pipeline for the discrimination of Parkinson’s disease, multiple system atrophy and healthy controlNemmi F, Pavy-Le Traon A, Phillips O.R, Galitzky M, Meissner W.G, Rascol O, Péran P
NeuroImage Clinical > 24- Discriminating between neurofibromatosis-1 and typically developing children by means of multimodal MRI and multivariate analysesNemmi F, Cignetti F, Assaiante C, Maziero S, Audic F, Péran P, Chaix Y Hum Brain Mapp.
2019;1–14 > 21- Discriminating between neurofibromatosis-1 and typically developing children by means of multimodal MRI and multivariate analyses.Nemmi F, Cignetti F, Assaiante C, Maziero S, Audic F, Péran P, Chaix Y.
Hum Brain Mapp. 2019 May 11. doi: 10.1002/hbm.24612. > 53- Action and Non-Action Oriented Body Representations: Insight from Behavioural and Grey Matter Modifications in Individuals with Lower Limb Amputation.Palermo L, Di Vita A, Boccia M, Nemmi F, Brunelli S, Traballesi M, De Giorgi R, Galati G, Guariglia C.
Biomed Res Int. 2018 Oct 18;2018:1529730. doi: 10.1155/2018/1529730. > 39- Multimodal Magnetic Resonance Imaging in Alzheimer’s Disease Patients at Prodromal Stage.Eustache P, Nemmi F, Saint-Aubert L, Pariente J, Péran P.
J Alzheimers Dis. 2016;50(4):1035-50. doi: 10.3233/JAD-150353. > Parkinson’s disease and local atrophy in subcortical nuclei: insight from shape analysis.Nemmi F, Sabatini U, Rascol O, Péran P.
Neurobiol Aging. 2015 Jan;36(1):424-33. doi: 10.1016/j.neurobiolaging.2014.07.010. > A case of logopenic primary progressive aphasia with C9ORF72 expansion and cortical florbetapir binding.Saint-Aubert L, Sagot C, Wallon D, Hannequin D, Payoux P, Nemmi F, Bezy C, Chauveau N, Campion D, Puel M, Chollet F, Pariente J.
J Alzheimers Dis. 2014;42(2):413-20. doi: 10.3233/JAD-140222. > Insight on AV-45 binding in white and grey matter from histogram analysis: a study on early Alzheimer’s disease patients and healthy subjects.Nemmi F, Saint-Aubert L, Adel D, Salabert AS, Pariente J, Barbeau EJ, Payoux P, Péran P.
Eur J Nucl Med Mol Imaging. 2014 Jul;41(7):1408-18. doi: 10.1007/s00259-014-2728-4. > Comparison between PET template-based method and MRI-based method for cortical quantification of florbetapir (AV-45) uptake in vivo.Saint-Aubert L, Nemmi F, Péran P, Barbeau EJ, Payoux P, Chollet F, Pariente J.
Eur J Nucl Med Mol Imaging. 2014 May;41(5):836-43. doi: 10.1007/s00259-013-2656-8.